Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641158 · ClinicalTrials.gov registry record · NA
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 422
- Enrollment target
NCT02641158 is a NA study that has completed, run by Columbia University. The registered enrollment target is 422 participants.
The verdict
NCT02641158, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
Study Summary
Primary Objective: This study will evaluate the effectiveness of an HCV Care Facilitation intervention in moving HIV/HCV co-infected substance users forward along the HCV care continuum (compared with a Control group). Primary Hypothesis: The number of steps achieved along the HCV care continuum will differ between the two study groups over the 14-month follow-up period. Secondary Objectives: Component 1 (Long-term CTN 0049 follow-up): Using the CTN 0064 baseline data (self-report, medical record abstraction and biological data), the following CTN 0049 primary and secondary outcomes in participants who consented to the CTN 0064 protocol will be re-analyzed to evaluate latent and/or enduring effects of the CTN 0049 interventions: 1. HIV virological suppression 2. HIV primary care visit attendance 3. All-cause mortality
Interventions
- OTHER Control Group
- BEHAVIORAL Care Facilitation Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641158
The ClinicalTrials.gov registry entry for NCT02641158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT02641158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02641158 about?
NCT02641158 is a clinical study titled "Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.". Primary Objective: This study will evaluate the effectiveness of an HCV Care Facilitation intervention in moving HIV/HCV co-infected substance users forward along the HCV care continuum (compared with a Control group). Primary Hypothesis: The number of steps achieved along the HCV care continuum wi...
What is the current status of trial NCT02641158?
This trial is currently completed. It is a NA study. The enrollment target is 422 participants. The study started on 2015-12. Estimated completion is 2018-05-09.
What interventions are being tested in trial NCT02641158?
The interventions under investigation include: Control Group (OTHER), Care Facilitation Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02641158?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.